About
Philip Fradkin holds a PhD from the University of Toronto and was an early employee at Deep Genomics, where he worked on machine learning applications for RNA, small molecules, and phenomics. He now leads efforts in AI for RNA design at Blank Bio and has published research at top machine learning and biology venues.
Phil Fradkin @phil_fradkin
We've made 20 years of RNA-seq searchable by concept. This improves agentic hypothesis generation: agents can reason in text and experimental spaces at once Read on for agentic science and a sneak peek at Ladon, our transcriptomic foundation model! https://t.co/uUhFiI4B8n
Jul 28, 2026 Β· β₯ 17 Β· β 2
Phil Fradkin @phil_fradkin
@PacBio Check out our blog to learn more and feel free to reach out to learn more https://t.co/NEqsu7z1yk
May 19, 2026 Β· β₯ 2 Β· β 1
Phil Fradkin @phil_fradkin
Excited to announce our collaboration with @PacBio! With this data we will be tuning our RNA foundation models for specific oncology indications to learn patient heterogeneity A single RNA seq sample is a ~600m dimensional readout. Join us to help extract every last bit https://t.co/xtpZJhqGAv
May 19, 2026 Β· β₯ 16
Founder at Blank BioYC S25
Intro paths
Philip went through Y Combinator (Summer 2025) β any YC alum in your network can reach them through the YC community.
Their group partner at YC was Ankit Gupta, General Partner at Y Combinator β the partner who ran Blank Bio's batch and knows the company first-hand. YC profile β
In turn, Philip can intro founders to Blank Bio's investors below.
